Kontermann RE - Search Results

1

Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity.

Siegemund M, Pollak N, Seifert O, Wahl K, Hanak K, Vogel A, Nussler AK, Göttsch D, Münkel S, Bantel H, Kontermann RE, Pfizenmaier K. Siegemund M, et al. Among authors: kontermann re. Cell Death Dis. 2012 Apr 12;3(4):e295. doi: 10.1038/cddis.2012.29. Cell Death Dis. 2012. PMID: 22495350 Free PMC article.

2

A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action.

Kontermann RE, Münkel S, Neumeyer J, Müller D, Branschädel M, Scheurich P, Pfizenmaier K. Kontermann RE, et al. J Immunother. 2008 Apr;31(3):225-34. doi: 10.1097/CJI.0b013e31816a88f9. J Immunother. 2008. PMID: 18317365

3

Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.

Messerschmidt SK, Musyanovych A, Altvater M, Scheurich P, Pfizenmaier K, Landfester K, Kontermann RE. Messerschmidt SK, et al. Among authors: kontermann re. J Control Release. 2009 Jul 1;137(1):69-77. doi: 10.1016/j.jconrel.2009.03.010. Epub 2009 Mar 21. J Control Release. 2009. PMID: 19306900

4

ATROSAB, a humanized antagonistic anti-tumor necrosis factor receptor one-specific antibody.

Zettlitz KA, Lorenz V, Landauer K, Münkel S, Herrmann A, Scheurich P, Pfizenmaier K, Kontermann R. Zettlitz KA, et al. MAbs. 2010 Nov-Dec;2(6):639-47. doi: 10.4161/mabs.2.6.13583. Epub 2010 Nov 1. MAbs. 2010. PMID: 20935477 Free PMC article.

5

Plasma half-life extension of small recombinant antibodies by fusion to immunoglobulin-binding domains.

Hutt M, Färber-Schwarz A, Unverdorben F, Richter F, Kontermann RE. Hutt M, et al. Among authors: kontermann re. J Biol Chem. 2012 Feb 10;287(7):4462-9. doi: 10.1074/jbc.M111.311522. Epub 2011 Dec 6. J Biol Chem. 2012. PMID: 22147690 Free PMC article.

6

Half-life extension of a single-chain diabody by fusion to domain B of staphylococcal protein A.

Unverdorben F, Färber-Schwarz A, Richter F, Hutt M, Kontermann RE. Unverdorben F, et al. Among authors: kontermann re. Protein Eng Des Sel. 2012 Feb;25(2):81-8. doi: 10.1093/protein/gzr061. Epub 2012 Jan 11. Protein Eng Des Sel. 2012. PMID: 22238430

7

Antibody-cytokine fusion proteins.

Kontermann RE. Kontermann RE. Arch Biochem Biophys. 2012 Oct 15;526(2):194-205. doi: 10.1016/j.abb.2012.03.001. Epub 2012 Mar 16. Arch Biochem Biophys. 2012. PMID: 22445675 Review.

8

An antibody fusion protein for cancer immunotherapy mimicking IL-15 trans-presentation at the tumor site.

Kermer V, Baum V, Hornig N, Kontermann RE, Müller D. Kermer V, et al. Among authors: kontermann re. Mol Cancer Ther. 2012 Jun;11(6):1279-88. doi: 10.1158/1535-7163.MCT-12-0019. Epub 2012 Apr 6. Mol Cancer Ther. 2012. PMID: 22491823

9

Combination of a bispecific antibody and costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy.

Hornig N, Kermer V, Frey K, Diebolder P, Kontermann RE, Müller D. Hornig N, et al. Among authors: kontermann re. J Immunother. 2012 Jun;35(5):418-29. doi: 10.1097/CJI.0b013e3182594387. J Immunother. 2012. PMID: 22576347

10

The IgM CH2 domain as covalently linked homodimerization module for the generation of fusion proteins with dual specificity.

Seifert O, Plappert A, Heidel N, Fellermeier S, Messerschmidt SK, Richter F, Kontermann RE. Seifert O, et al. Among authors: kontermann re. Protein Eng Des Sel. 2012 Oct;25(10):603-12. doi: 10.1093/protein/gzs059. Epub 2012 Sep 17. Protein Eng Des Sel. 2012. PMID: 22988132

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters